A Pintiaux, U Gaspard, M Nisolle
Index: Rev. Med. Liege. 67(3) , 152-6, (2012)
Full Text: HTML
A new combined oral contraceptive called Zoely has just been marketed in Belgium. It contains nomegestrol acetate, a progestin known for its high contraceptive reliability based on its antigonadotropic power and long half-life. This progestin is associated with estradiol and Zoely is devoid of ethinyl estradiol, which is the usual component of the majority of combined oral contraceptives and is primarily responsible for thrombotic side effects of the pill. The compositon and type of regimen of this new oral contraceptive contribute to its efficacy and excellent clinical tolerance.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Nomegestrol acetate
CAS:58652-20-3 |
C23H30O4 |
|
Changing convention in combination oral contraceptives: estr...
2013-07-01 [J. Fam. Plann. Reprod. Health Care 39(3) , 211-6, (2013)] |
|
A new contraceptive pill containing 17β-estradiol and nomege...
2013-01-01 [Womens. Health (Lond. Engl.) 9(1) , 13-23, (2013)] |
|
The “newer” progestogens and postmenopausal hormone therapy ...
2014-07-01 [J. Steroid Biochem. Mol. Biol. 142 , 48-51, (2014)] |
|
Comparison of a 24-day and a 21-day pill regimen for the nov...
2011-06-01 [Hum. Reprod. 26(6) , 1338-47, (2011)] |
|
Inhibition of ovulation by NOMAC/E2, a novel monophasic oral...
2011-04-01 [Eur. J. Contracept. Reprod. Health Care 16(2) , 76-84, (2011)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
